Suchergebnisse - "Chou, Cheng-Yang"

PubPharm (84)

1

The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells

enthalten in: Journal of ovarian research | 2023

von Wu, Y. | Huang, Y. | Wu, P. | +3

UpdateOf: Res Sq. 2023 Feb 20;:. - PMID 36865240

2

Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in Ovarian Clear Cell Carcinoma : A Multi-Institutional Cohort Study

enthalten in: Cancers | 2022

von Chou, C. | Cheng, W. | Chen, M. | +7

3

Collagen XI Alpha 1 Chain, a Novel Therapeutic Target for Cancer Treatment

enthalten in: Frontiers in oncology | 2022

von Wu, Y. | Chou, C.

4

miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1

enthalten in: Cancers | 2021

von Wu, Y. | Huang, Y. | Chang, T. | +5

5

COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells

enthalten in: Oncogene | 2021

von Wu, Y. | Huang, Y. | Chang, T. | +4

6

Targeting the Copper Transport System to Improve Treatment Efficacies of Platinum-Containing Drugs in Cancer Chemotherapy

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2021

von Kuo, M. | Huang, Y. | Chou, C. | +1

7

Chemoresistant ovarian cancer enhances its migration abilities by increasing store-operated Ca2+ entry-mediated turnover of focal adhesions

enthalten in: Journal of biomedical science | 2020

von Huang, H. | Lin, Y. | Chang, H. | +5

8

Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment

enthalten in: Frontiers in pharmacology | 2020

von Wu, Y. | Huang, Y. | Chen, C. | +2

9

Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT) : 8-Year Experience

enthalten in: Frontiers in oncology | 2020

von Wu, P. | Cheng, Y. | Shen, M. | +3

10

Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression

enthalten in: Cell death & disease | 2019

von Wu, Y. | Huang, Y. | Chen, C. | +1

1
2
3
4
5
6
7
8
9
Nächster »
[9]